NORD logo

Norda OTCNO:NORD Stock Report

Last Price

kr41.00

Market Cap

kr203.8m

7D

0%

1Y

n/a

Updated

16 Jun, 2024

Data

Company Financials

Norda ASA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Norda
Historical stock prices
Current Share Pricekr41.00
52 Week Highkr0
52 Week Lowkr0
Beta0.22
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change7.89%
5 Year Change127.78%
Change since IPO-99.59%

Recent News & Updates

Recent updates

Shareholder Returns

NORDNO BiotechsNO Market
7D0%-3.5%-2.2%
1Yn/a-51.5%2.1%

Return vs Industry: Insufficient data to determine how NORD performed against the Norwegian Biotechs industry.

Return vs Market: Insufficient data to determine how NORD performed against the Norwegian Market.

Price Volatility

Is NORD's price volatile compared to industry and market?
NORD volatility
NORD Average Weekly Movementn/a
Biotechs Industry Average Movement8.9%
Market Average Movement5.0%
10% most volatile stocks in NO Market11.0%
10% least volatile stocks in NO Market3.1%

Stable Share Price: NORD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NORD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021Frode Westvoldwww.nordasa.no

Norda ASA, a biotechnology company, engages in the cancer diagnostic activities. The company is involved in the research and development of Genefec, a diagnostic screening test for colorectal cancer. It also invests and trades in securities, real estates, and other assets.

Norda ASA Fundamentals Summary

How do Norda's earnings and revenue compare to its market cap?
NORD fundamental statistics
Market capkr203.80m
Earnings (TTM)kr100.24m
Revenue (TTM)kr127.97m

2.0x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NORD income statement (TTM)
Revenuekr127.97m
Cost of Revenuekr0
Gross Profitkr127.97m
Other Expenseskr27.73m
Earningskr100.24m

Last Reported Earnings

Dec 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)20.17
Gross Margin100.00%
Net Profit Margin78.33%
Debt/Equity Ratio109.2%

How did NORD perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.